KCNMA1 and melanoma: In the present study, we employed different BK channel activators [20,22,33,34] (Figure 1) in order to explore the feasibility to modulate BK channel function to reduce cell viability, proliferation, and migration in two different cancer lines, i.e., melanoma (IGR39) and PDAC (Panc-1).